TwinBeech Capital’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $692K | Sell |
46,730
-125,219
| -73% | -$1.85M | 0.02% | 460 |
|
|
2025
Q1 | $3.08M | Buy |
171,949
+161,780
| +1,591% | +$2.9M | 0.06% | 328 |
|
|
2024
Q4 | $177K | Buy |
+10,169
| New | +$177K | ﹤0.01% | 567 |
|
|
2024
Q2 | – | Sell |
-14,718
| Closed | -$113K | – | 789 |
|
|
2024
Q1 | $113K | Sell |
14,718
-5,859
| -28% | -$45.2K | ﹤0.01% | 507 |
|
|
2023
Q4 | $185K | Sell |
20,577
-208,209
| -91% | -$1.87M | ﹤0.01% | 603 |
|
|
2023
Q3 | $2.05M | Buy |
228,786
+56,940
| +33% | +$509K | 0.04% | 409 |
|
|
2023
Q2 | $2.64M | Buy |
171,846
+39,218
| +30% | +$602K | 0.05% | 350 |
|
|
2023
Q1 | $2.98M | Buy |
132,628
+104,855
| +378% | +$2.36M | 0.06% | 321 |
|
|
2022
Q4 | $584K | Sell |
27,773
-48,831
| -64% | -$1.03M | 0.01% | 578 |
|
|
2022
Q3 | $1.89M | Buy |
+76,604
| New | +$1.89M | 0.05% | 345 |
|